AGX

Business Context and Reporting Period

Company: Argan, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: October 31, 2009
Business Overview: Argan operates through three wholly-owned subsidiaries: Gemma Power Systems (GPS) providing power industry services; Vitarich Laboratories (VLI) manufacturing nutritional products; and Southern Maryland Cable (SMC) providing telecommunications infrastructure services. The Company is an accelerated filer and is not a shell company.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Consolidated net revenues increased 47% ($19.3 million) for the quarter and 15% ($24.3 million) for the nine months compared to the prior year. This was driven primarily by a 49% increase in Power Industry Services revenue due to construction activity on a natural gas-fired plant in California.
• Profitability: Net income for the quarter decreased 25% to $2.0 million from $2.6 million, primarily due to a $925,000 increase in selling, general, and administrative (SG&A) expenses. However, year-to-date net income increased 53% to $7.6 million, aided by the absence of a $1.9 million impairment loss recorded in the prior year related to VLI.
• Cash Flow: Operating activities used $20.5 million in cash for the nine months, a significant shift from the $6.3 million provided in the prior year. This was caused by a $22.8 million increase in "costs and estimated earnings in excess of billings" and a $14.0 million reduction in accounts payable.
• Debt Reduction: Long-term debt was reduced by $1.8 million during the period, with a total outstanding balance of approximately $2.3 million.

Outlook, Risks, and Contingencies

• Acquisition Activity: In August 2009, Argan signed a non-binding letter of intent to acquire United American Steel Constructors, Inc. (UNAMSCO) for approximately $50 million (cash and stock). The deal is subject to due diligence and board approval. Financing negotiations with the Bank of America are underway to cover the cash portion.
• Customer Concentration: The Company faces significant concentration risk. One customer accounted for approximately 88% of consolidated net revenues for both the three and nine months ended October 31, 2009.
• Legal Proceedings:
  • Kevin Thomas Litigation: Settled in September 2009 with a $60,000 cash payment.
  • Tampa Bay Nutraceutical Company: Pending lawsuit alleging breach of contract and fraud with claimed damages exceeding $40 million. Management believes it has meritorious defenses but cannot estimate potential damages.
• Economic Risks: Management notes that the ongoing economic recession and credit market disruptions could lead to project delays or cancellations, particularly for projects funded by private investment.
• Guidance: Management expects profitable operating results for the remainder of the fiscal year based on the scheduled performance of the GPS contract backlog.

Investor Verification Checklist

• Customer Dependency: Verify the status and financial health of the single customer representing 88% of recent revenues.
• UNAMSCO Acquisition: Monitor the progress of due diligence and the finalization of financing terms for the proposed $50 million acquisition.
• Operating Cash Flow: Assess the timing of billings for the $22.8 million increase in unbilled costs to ensure collection in the upcoming period.
• Legal Exposure: Track developments in the Tampa Bay Nutraceutical litigation regarding the $40 million claim.
• Debt Covenants: Confirm continued compliance with Bank of America covenants, specifically the debt-to-EBITDA ratios, especially given the potential leverage from the UNAMSCO deal.